Beta-Blockers Post-MI Past Their Expiration Date: REDUCE-AMI
REDUCE-AMI showed no benefit for routine beta-blockers post–MI in patients with normal ejection fraction. John Mandrola, MD, asks: Does evidence-based medicine need expiration dates?
REDUCE-AMI showed no benefit for routine beta-blockers post–MI in patients with normal ejection fraction. John Mandrola, MD, asks: Does evidence-based medicine need expiration dates?
Notable treatment advances have been made in recent years for patients with myelodysplastic syndromes/neoplasms (MDS), and several new drugs are under development. For example, the…
We have facilitated a network of 150 myeloma-specific support groups that hold regular meetings in the U.S. So no matter where you are, we can…
Background Scoping reviews are a relatively new approach to evidence synthesis and currently there exists little guidance regarding the decision to choose between a systematic…
Myeloma Paper of the Day, May 21st, suggested by Robert Orlowski / Alaa Shehadeh, Aseel Ishtay, Batia Avni, cancer, Cyrille Cohen, Eran Zimran, Eyal Lebel,
This systematic review and meta-analysis examines whether patient participation in cancer trials is associated with greater survival benefit compared with routine care.
It was both moving and onerous that she trusted me with important decisions, and I treasure her observation that our relationship never felt transactional
Evolutionary psychology has developed an uncomfortable relationship with provocateurs and incel ideology.
View this file, and add comments too.
Multiscale mathematical modeling combined with biomarker dynamics during adaptive therapy helps identify underlying features of metastatic cancer to inform treatment decisions.
People who vaped and smoked cigarettes appeared four times more likely to develop lung cancer compared with those who only smoked, according to study results…